This study assessed nutrient intake in adults using GLP-1 receptor agonists (GLP-1RAs) and found widespread deficiencies in ...

The U.S. District Court for the District of Maine recently dismissed two separate suits alleging that health plans’ coverage ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Children who are living with severe obesity are more likely to experience a clinically relevant change in BMI when GLP-1 ...

The diabetes and weight loss drugs are “not cost-effective at their current prices, and are largely unavailable to people with lower incomes,” the report said.

Prescription drug spending in the United States rose by 10.2% last year, thanks in part to the popularity of GLP weight-loss ...

The best metric is not weight, but a particularly toxic kind of fat.

New research being presented at the European Congress on Obesity (ECO 2025) has found that patients of an online obesity ...

A study has found that glucagon-like peptide-1 receptor agonists (GLP-1RAs) offer anti-cancer benefits that extend beyond ...

David Kessler has lost more than 60 pounds on weight-loss drugs and believes they can change the trajectory of chronic ...

Step into physical therapy professor Anjana Bhat's colorful Move 2 Learn Innovation Lab on the University of Delaware's Science, Technology and Advanced Research (STAR) Campus, and you may see ...